| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Greenlee was Program Director for Cancer Surveillance in the Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA. He is currently a lead scientist with the Marshfield Medical Research Foundation, Marshfield, WI.
Ms. Hill-Harmon is an Epidemiologist in the Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, in the Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice-President of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year the American Cancer Society compiles estimates of the number of new cancer cases and deaths expected in the US in the current year and the most recent data on cancer incidence, mortality, and survival. An estimated 1,268,000 new cases of cancer will be diagnosed in the year 2001 and an estimated 553,400 Americans will die from cancer. Overall cancer incidence and death rates have continued to decrease in men and women since the early 1990s, and the decline in overall cancer mortality has been greater in recent years. Despite reductions in age-adjusted rates of cancer death, the total number of recorded cancer deaths in the US continues to increase, due to an aging and expanding population. Large disparities in cancer incidence and mortality across racial/ethnic groups continue. Black men and women experience higher incidence of cancer and poorer survival than white men and women. The disparity in survival reflects both diagnosis of cancer at later disease stages, and poorer survival within each stage of diagnosis.
This article has been cited by other articles:
|
|
 |
|
  A.-S. Bats, V. Lavoue, R. Rouzier, C. Coutant, K. Kerrou, and E. Darai Limits of Day-Before Lymphoscintigraphy to Localize Sentinel Nodes in Women with Cervical Cancer Ann. Surg. Oncol., August 1, 2008; 15(8): 2173 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schepeler, J. T. Reinert, M. S. Ostenfeld, L. L. Christensen, A. N. Silahtaroglu, L. Dyrskjot, C. Wiuf, F. J. Sorensen, M. Kruhoffer, S. Laurberg, et al. Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer Cancer Res., August 1, 2008; 68(15): 6416 - 6424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Shugarman, M. E.S. Sorbero, H. Tian, A. K. Jain, and J. S. Ashwood An Exploration of Urban and Rural Differences in Lung Cancer Survival Among Medicare Beneficiaries Am J Public Health, July 1, 2008; 98(7): 1280 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaulfuss, M. Grzmil, B. Hemmerlein, P. Thelen, S. Schweyer, J. Neesen, L. Bubendorf, A. G. Glass, H. Jarry, B. Auber, et al. Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells Mol. Endocrinol., July 1, 2008; 22(7): 1606 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tsuruta, L. Pereboeva, M. Breidenbach, D. T. Rein, M. Wang, R. D. Alvarez, G. P. Siegal, P. Dent, P. B. Fisher, and D. T. Curiel A Fiber-Modified Mesothelin Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3582 - 3588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S.M. Diefenbach, S. Gnjatic, P. Sabbatini, C. Aghajanian, M. L. Hensley, D. R. Spriggs, A. Iasonos, H. Lee, B. Dupont, S. Pezzulli, et al. Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission Clin. Cancer Res., May 1, 2008; 14(9): 2740 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Bhosale, M. Patnana, C. Viswanathan, and J. Szklaruk The Inguinal Canal: Anatomy and Imaging Features of Common and Uncommon Masses RadioGraphics, May 1, 2008; 28(3): 819 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kato, N. Sato, A. Takano, M. Miyamoto, H. Nishimura, E. Tsuchiya, S. Kondo, Y. Nakamura, and Y. Daigo Activation of Placenta-Specific Transcription Factor Distal-less Homeobox 5 Predicts Clinical Outcome in Primary Lung Cancer Patients Clin. Cancer Res., April 15, 2008; 14(8): 2363 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Mandel, J. W. Tanner, G. R. Lichtenstein, D. C. Metz, D. A. Katzka, G. G. Ginsberg, and M. L. Kochman A Randomized, Controlled, Double-Blind Trial of Patient-Controlled Sedation with Propofol/Remifentanil Versus Midazolam/Fentanyl for Colonoscopy Anesth. Analg., February 1, 2008; 106(2): 434 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kocakoc, A. Kiris, I. Orhan, A. K. Poyraz, H. Artas, and F. Firdolas Detection of Bladder Tumors With 3-Dimensional Sonography and Virtual Sonographic Cystoscopy J. Ultrasound Med., January 1, 2008; 27(1): 45 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Tang, T.-W. Tan, W.-M. Fu, and R.-S. Yang Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis Carcinogenesis, January 1, 2008; 29(1): 35 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Taniwaki, A. Takano, N. Ishikawa, W. Yasui, K. Inai, H. Nishimura, E. Tsuchiya, N. Kohno, Y. Nakamura, and Y. Daigo Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6624 - 6631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Kim, M. K. Kee, S. A. Chong, and M. J. Nam Galanin Is Up-Regulated in Colon Adenocarcinoma Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2373 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Visus, D. Ito, A. Amoscato, M. Maciejewska-Franczak, A. Abdelsalem, R. Dhir, D. M. Shin, V. S. Donnenberg, T. L. Whiteside, and A. B. DeLeo Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck Cancer Res., November 1, 2007; 67(21): 10538 - 10545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Chang, S. J. Mentzer, Y. L. Colson, P. A. Linden, M. T. Jaklitsch, S. R. Lipsitz, and D. J. Sugarbaker Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 850 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sharma, J. Tammela, X. Wang, H. Arnouk, D. Driscoll, P. Mhawech-Fauceglia, S. Lele, A. L. Kazim, and K. Odunsi Characterization of a Putative Ovarian Oncogene, Elongation Factor 1{alpha}, Isolated by Panning a Synthetic Phage Display Single-Chain Variable Fragment Library with Cultured Human Ovarian Cancer Cells Clin. Cancer Res., October 1, 2007; 13(19): 5889 - 5896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.-G. Liu, H. Alder, et al. MicroRNA Signatures in Human Ovarian Cancer Cancer Res., September 15, 2007; 67(18): 8699 - 8707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Coutant, E Barranger, A Cortez, D Dabit, S Uzan, J. Bernaudin, and E Darai Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer Ann. Onc., September 1, 2007; 18(9): 1513 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Kennedy, A. McWilliams, E. Edell, T. Sutedja, G. Downie, R. Yung, A. Gazdar, and P. N. Mathur Bronchial Intraepithelial Neoplasia/Early Central Airways Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 221S - 233S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Cotrim, F. Hyodo, K.-I. Matsumoto, A. L. Sowers, J. A. Cook, B. J. Baum, M. C. Krishna, and J. B. Mitchell Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance Imaging Clin. Cancer Res., August 15, 2007; 13(16): 4928 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Coutant, O. Morel, Y. Delpech, S. Uzan, E. Darai, and E. Barranger Laparoscopic Sentinel Node Biopsy in Cervical Cancer Using a Combined Detection: 5 Years Experience Ann. Surg. Oncol., August 1, 2007; 14(8): 2392 - 2399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohno, H. Koyama, M. Nogami, D. Takenaka, S. Matsumoto, M. Yoshimura, Y. Kotani, and K. Sugimura Postoperative Lung Function in Lung Cancer Patients: Comparative Analysis of Predictive Capability of MRI, CT, and SPECT Am. J. Roentgenol., August 1, 2007; 189(2): 400 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Mutch, M. Orlando, T. Goss, M. G. Teneriello, A. N. Gordon, S. D. McMeekin, Y. Wang, D. R. Scribner Jr, M. Marciniack, R. W. Naumann, et al. Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer J. Clin. Oncol., July 1, 2007; 25(19): 2811 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamamoto, Y. Tomita, Y. Hoshida, E. Morii, T. Yasuda, Y. Doki, K. Aozasa, H. Uyama, H. Nakamura, and M. Monden Expression Level of Hepatoma-Derived Growth Factor Correlates with Tumor Recurrence of Esophageal Carcinoma Ann. Surg. Oncol., July 1, 2007; 14(7): 2141 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Smyth, C. Gourley, G. Walker, M. J. MacKean, A. Stevenson, A. R.W. Williams, A. A. Nafussi, T. Rye, R. Rye, M. Stewart, et al. Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor-Positive Patients Clin. Cancer Res., June 15, 2007; 13(12): 3617 - 3622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. O'Connor, M. C. Farach-Carson, C. J. Schneider, and D. D. Carson Coculture with Prostate Cancer Cells Alters Endoglin Expression and Attenuates Transforming Growth Factor-{beta} Signaling in Reactive Bone Marrow Stromal Cells Mol. Cancer Res., June 1, 2007; 5(6): 585 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zundelevich, G. Elad-Sfadia, R. Haklai, and Y. Kloog Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid) Mol. Cancer Ther., June 1, 2007; 6(6): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Frederick, B. A. Helfrich, C. D. Coldren, D. Zheng, D. Chan, P. A. Bunn Jr., and D. Raben Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma Mol. Cancer Ther., June 1, 2007; 6(6): 1683 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayama, Y. Daigo, T. Yamabuki, D. Hirata, T. Kato, M. Miyamoto, T. Ito, E. Tsuchiya, S. Kondo, and Y. Nakamura Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis Cancer Res., May 1, 2007; 67(9): 4113 - 4122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wu, Z. Guo, X. Chang, M. S. Kim, J. K. Nagpal, J. Liu, J. M. Maki, K. I. Kivirikko, S. P. Ethier, B. Trink, et al. LOXL1 and LOXL4 Are Epigenetically Silenced and Can Inhibit Ras/Extracellular Signal-Regulated Kinase Signaling Pathway in Human Bladder Cancer Cancer Res., May 1, 2007; 67(9): 4123 - 4129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-y. Tang, Y.-q. Zhu, W.-h. Tao, B. Wei, and X.-l. Lin Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma Postgrad. Med. J., May 1, 2007; 83(979): 338 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lu, Z. Cai, G. Xiao, E. T. Keller, A. Mizokami, Z. Yao, G. D. Roodman, and J. Zhang Monocyte Chemotactic Protein-1 Mediates Prostate Cancer-Induced Bone Resorption Cancer Res., April 15, 2007; 67(8): 3646 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schleicher, C. Poremba, H. Wolters, K.-L. Schafer, N. Senninger, and M. Colombo-Benkmann Gain of Chromosome 8q: A Potential Prognostic Marker in Resectable Adenocarcinoma of the Pancreas? Ann. Surg. Oncol., April 1, 2007; 14(4): 1327 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Saar, A Meining, A Beer, M Settles, H Helmberger, E Frimberger, E J Rummeny, and T Rosch Prospective study on bright lumen magnetic resonance colonography in comparison with conventional colonoscopy Br. J. Radiol., April 1, 2007; 80(952): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Puppala, C.G. Gairola, and H.I. Swanson Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation Carcinogenesis, March 1, 2007; 28(3): 639 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang and A. Chang Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer J. Med. Genet., March 1, 2007; 44(3): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lagman, N. Rivera, D. Walsh, S. LeGrand, and M. P. Davis Acute Inpatient Palliative Medicine in a Cancer Center: Clinical Problems and Medical Interventions--A Prospective Study American Journal of Hospice and Palliative Medicine, February 1, 2007; 24(1): 20 - 28. [Abstract] [PDF]
|
|
|
|
|
|
C. Suzuki, K. Takahashi, S. Hayama, N. Ishikawa, T. Kato, T. Ito, E. Tsuchiya, Y. Nakamura, and Y. Daigo Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer Mol. Cancer Ther., February 1, 2007; 6(2): 542 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aghdassi, P. Phillips, V. Dudeja, D. Dhaulakhandi, R. Sharif, R. Dawra, M. M. Lerch, and A. Saluja Heat Shock Protein 70 Increases Tumorigenicity and Inhibits Apoptosis in Pancreatic Adenocarcinoma Cancer Res., January 15, 2007; 67(2): 616 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kato, S. Hayama, T. Yamabuki, N. Ishikawa, M. Miyamoto, T. Ito, E. Tsuchiya, S. Kondo, Y. Nakamura, and Y. Daigo Increased Expression of Insulin-like Growth Factor-II Messenger RNA-Binding Protein 1 Is Associated with Tumor Progression in Patients with Lung Cancer Clin. Cancer Res., January 15, 2007; 13(2): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Edell High-grade lesion: what does it tell us? Thorax, January 1, 2007; 62(1): 2 - 3. [Full Text] [PDF]
|
|
|
|
|
|
S. Ueda, K. Fukamachi, Y. Matsuoka, N. Takasuka, F. Takeshita, A. Naito, M. Iigo, D. B. Alexander, M. A. Moore, I. Saito, et al. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas Carcinogenesis, December 1, 2006; 27(12): 2497 - 2510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kyrgiou, G. Salanti, N. Pavlidis, E. Paraskevaidis, and J. P. A. Ioannidis Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments. J Natl Cancer Inst, November 15, 2006; 98(22): 1655 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Griffith, A. Melck, S. J.M. Jones, and S. M. Wiseman Meta-Analysis and Meta-Review of Thyroid Cancer Gene Expression Profiling Studies Identifies Important Diagnostic Biomarkers J. Clin. Oncol., November 1, 2006; 24(31): 5043 - 5051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bloom, S. L. Stewart, I. Oakley-Girvans, P. J. Banks, and S. Chang Family History, Perceived Risk, and Prostate Cancer Screening among African American Men. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.J. Mao, W.V. Giannobile, J.A. Helms, S.J. Hollister, P.H. Krebsbach, M.T. Longaker, and S. Shi Craniofacial tissue engineering by stem cells. J. Dent. Res., November 1, 2006; 85(11): 966 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayama, Y. Daigo, T. Kato, N. Ishikawa, T. Yamabuki, M. Miyamoto, T. Ito, E. Tsuchiya, S. Kondo, and Y. Nakamura Activation of CDCA1-KNTC2, Members of Centromere Protein Complex, Involved in Pulmonary Carcinogenesis Cancer Res., November 1, 2006; 66(21): 10339 - 10348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Litman, S. Bhasin, C. L. Link, A. B. Araujo, J. B. McKinlay, and for the Boston Area Community Health Survey Invest Serum Androgen Levels in Black, Hispanic, and White Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4326 - 4334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S L El Sharkawy, N F Abbas, M A Badawi, and M A El Shaer Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions J. Clin. Pathol., November 1, 2006; 59(11): 1171 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pectasides, E. Pectasides, A. Psyrri, and T. Economopoulos Treatment Issues in Clear Cell Carcinoma of the Ovary: A Different Entity? Oncologist, November 1, 2006; 11(10): 1089 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, L. Ngo, G. Perez, M. Dokmanovic, and P. A. Marks Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor PNAS, October 17, 2006; 103(42): 15540 - 15545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, C. Furukawa, A. Takano, N. Ishikawa, T. Kato, S. Hayama, C. Suzuki, W. Yasui, K. Inai, S. Sone, et al. The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer Cancer Res., October 1, 2006; 66(19): 9408 - 9419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li and B. C. Tai RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis. Clin. Cancer Res., October 1, 2006; 12(19): 5713 - 5719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Munday, M. M. Brennan, and M. Kiupel Altered Expression of {beta}-catenin, E-cadherin, Cycloxygenase-2, and p53 Protein by Ovine Intestinal Adenocarcinoma Cells. Vet. Pathol., September 1, 2006; 43(5): 613 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer Arch Surg, August 1, 2006; 141(8): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Hoque, S. Begum, O. Topaloglu, A. Chatterjee, E. Rosenbaum, W. Van Criekinge, W. H. Westra, M. Schoenberg, M. Zahurak, S. N. Goodman, et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst, July 19, 2006; 98(14): 996 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
